In the Press: New Beauty

Is Microdosing GLP-1s the next big health hack?

In a recent interview with NewBeauty, I discussed the emerging trend of microdosing GLP-1 medications, such as Ozempic and Wegovy, which are traditionally used for weight loss.

I shared insights on how individuals are exploring lower, off-label doses of these drugs to address various health concerns, including inflammation, polycystic ovary syndrome (PCOS), and cardiovascular health.

While some anecdotal reports suggest benefits like reduced inflammation and improved management of certain conditions, I emphasized the necessity for more comprehensive research to fully understand the long-term effects and safety of this practice.

I also cautioned readers to consult with healthcare professionals before considering microdosing, as it is not FDA-approved and may not be suitable for everyone.

"GLP-1s work in a dose-dependent way—the higher the dose, the more appetite suppression." She also notes that some patients respond well to lower doses for weight loss or maintenance. Additionally, Dr. Kahn shares, "In my longevity practice, I prescribe very low doses to combat inflammation."

Read the full article here.